Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Invested Capital (2021 - 2022)

Ovid Therapeutics filings provide 2 years of Return on Invested Capital readings, the most recent being 0.0% for Q4 2022.

  • Quarterly Return on Invested Capital fell 1.0% to 0.0% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2022, down 1.0% year-over-year, with the annual reading at 0.01% for FY2021, N/A changed from the prior year.
  • Return on Invested Capital hit 0.0% in Q4 2022 for Ovid Therapeutics, up from 0.0% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.01% in Q4 2021 and bottomed at 0.0% in Q3 2022.